419 related articles for article (PubMed ID: 29486302)
1. Brain targeting of resveratrol by nasal administration of chitosan-coated lipid microparticles.
Trotta V; Pavan B; Ferraro L; Beggiato S; Traini D; Des Reis LG; Scalia S; Dalpiaz A
Eur J Pharm Biopharm; 2018 Jun; 127():250-259. PubMed ID: 29486302
[TBL] [Abstract][Full Text] [Related]
2. Enhancement of in vivo human skin penetration of resveratrol by chitosan-coated lipid microparticles.
Scalia S; Trotta V; Iannuccelli V; Bianchi A
Colloids Surf B Biointerfaces; 2015 Nov; 135():42-49. PubMed ID: 26241915
[TBL] [Abstract][Full Text] [Related]
3. Preparation and characterization of dutasteride-loaded nanostructured lipid carriers coated with stearic acid-chitosan oligomer for topical delivery.
Noor NM; Sheikh K; Somavarapu S; Taylor KMG
Eur J Pharm Biopharm; 2017 Aug; 117():372-384. PubMed ID: 28412472
[TBL] [Abstract][Full Text] [Related]
4. Resveratrol solid lipid microparticles as dry powder formulation for nasal delivery, characterization and in vitro deposition study.
Martignoni I; Trotta V; Lee WH; Loo CY; Pozzoli M; Young PM; Scalia S; Traini D
J Microencapsul; 2016 Dec; 33(8):735-742. PubMed ID: 27841060
[TBL] [Abstract][Full Text] [Related]
5. Skin Delivery and in Vitro Biological Evaluation of Trans-Resveratrol-Loaded Solid Lipid Nanoparticles for Skin Disorder Therapies.
Rigon RB; Fachinetti N; Severino P; Santana MH; Chorilli M
Molecules; 2016 Jan; 21(1):E116. PubMed ID: 26805794
[TBL] [Abstract][Full Text] [Related]
6. Enhancement of
Scalia S; Zampino MR; Trotta V; Bianchi A
Pharmazie; 2017 Apr; 72(4):200-204. PubMed ID: 29441987
[TBL] [Abstract][Full Text] [Related]
7. Novel resveratrol smart lipids; design, formulation, and biological evaluation of anticancer activity.
Diab RF; Abdelghany TM; Gad S; Elbakry AM
J Pharm Pharmacol; 2024 Jun; 76(6):631-645. PubMed ID: 38507715
[TBL] [Abstract][Full Text] [Related]
8. Solid microparticles based on chitosan or methyl-β-cyclodextrin: a first formulative approach to increase the nose-to-brain transport of deferoxamine mesylate.
Rassu G; Soddu E; Cossu M; Brundu A; Cerri G; Marchetti N; Ferraro L; Regan RF; Giunchedi P; Gavini E; Dalpiaz A
J Control Release; 2015 Mar; 201():68-77. PubMed ID: 25620068
[TBL] [Abstract][Full Text] [Related]
9. Fabrication of an ionic-sensitive in situ gel loaded with resveratrol nanosuspensions intended for direct nose-to-brain delivery.
Hao J; Zhao J; Zhang S; Tong T; Zhuang Q; Jin K; Chen W; Tang H
Colloids Surf B Biointerfaces; 2016 Nov; 147():376-386. PubMed ID: 27566226
[TBL] [Abstract][Full Text] [Related]
10. Preparation and in vitro/in vivo evaluation of resveratrol-loaded carboxymethyl chitosan nanoparticles.
Zu Y; Zhang Y; Wang W; Zhao X; Han X; Wang K; Ge Y
Drug Deliv; 2016; 23(3):981-91. PubMed ID: 24918466
[TBL] [Abstract][Full Text] [Related]
11. Non-invasive intranasal delivery of quetiapine fumarate loaded microemulsion for brain targeting: Formulation, physicochemical and pharmacokinetic consideration.
Shah B; Khunt D; Misra M; Padh H
Eur J Pharm Sci; 2016 Aug; 91():196-207. PubMed ID: 27174656
[TBL] [Abstract][Full Text] [Related]
12. Trans-nasal zolmitriptan novasomes: in-vitro preparation, optimization and in-vivo evaluation of brain targeting efficiency.
Abd-Elal RM; Shamma RN; Rashed HM; Bendas ER
Drug Deliv; 2016 Nov; 23(9):3374-3386. PubMed ID: 27128792
[TBL] [Abstract][Full Text] [Related]
13. Brain uptake of a Zidovudine prodrug after nasal administration of solid lipid microparticles.
Dalpiaz A; Ferraro L; Perrone D; Leo E; Iannuccelli V; Pavan B; Paganetto G; Beggiato S; Scalia S
Mol Pharm; 2014 May; 11(5):1550-61. PubMed ID: 24717116
[TBL] [Abstract][Full Text] [Related]
14. Preparation of estradiol chitosan nanoparticles for improving nasal absorption and brain targeting.
Wang X; Chi N; Tang X
Eur J Pharm Biopharm; 2008 Nov; 70(3):735-40. PubMed ID: 18684400
[TBL] [Abstract][Full Text] [Related]
15. Chitosan coated sodium alginate-chitosan nanoparticles loaded with 5-FU for ocular delivery: in vitro characterization and in vivo study in rabbit eye.
Nagarwal RC; Kumar R; Pandit JK
Eur J Pharm Sci; 2012 Nov; 47(4):678-85. PubMed ID: 22922098
[TBL] [Abstract][Full Text] [Related]
16. Application of RPMI 2650 as a cell model to evaluate solid formulations for intranasal delivery of drugs.
Gonçalves VSS; Matias AA; Poejo J; Serra AT; Duarte CMM
Int J Pharm; 2016 Dec; 515(1-2):1-10. PubMed ID: 27702697
[TBL] [Abstract][Full Text] [Related]
17. Alginate coated chitosan microparticles mediated oral delivery of diphtheria toxoid. Part A. Systematic optimization, development and characterization.
Shukla A; Mishra V; Bhoop BS; Katare OP
Int J Pharm; 2015 Nov; 495(1):220-233. PubMed ID: 26319633
[TBL] [Abstract][Full Text] [Related]
18. Bile salt-coating modulates the macrophage uptake of nanocores constituted by a zidovudine prodrug and enhances its nose-to-brain delivery.
Dalpiaz A; Fogagnolo M; Ferraro L; Beggiato S; Hanuskova M; Maretti E; Sacchetti F; Leo E; Pavan B
Eur J Pharm Biopharm; 2019 Nov; 144():91-100. PubMed ID: 31521715
[TBL] [Abstract][Full Text] [Related]
19. Co-encapsulated resveratrol and quercetin in chitosan and peg modified chitosan nanoparticles: For efficient intra ocular pressure reduction.
Natesan S; Pandian S; Ponnusamy C; Palanichamy R; Muthusamy S; Kandasamy R
Int J Biol Macromol; 2017 Nov; 104(Pt B):1837-1845. PubMed ID: 28472691
[TBL] [Abstract][Full Text] [Related]
20. Formulation and Evaluation of Neuroactive Drug Loaded Chitosan Nanoparticle for Nose to Brain Delivery: In-vitro Characterization and In-vivo Behavior Study.
Qureshi M; Aqil M; Imam SS; Ahad A; Sultana Y
Curr Drug Deliv; 2019; 16(2):123-135. PubMed ID: 30317997
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
